ArcBest ARCB 深 滬
等待開盤 09-24 09:30:00 美东时间
131.08
-0.630
-0.48%
華盛通- 最 高133.16
- 今 開131.67
- 成交量 14.92万股
- 最 低 128.57
- 昨 收 131.71
- 總市值 29.30亿
- 52周最高 176.5657
- 市盈率 靜 50.02
- 換手率 0.67%
- 52周最低 59.07
- 委 比 -80.11%
- 總股本 2235.14万
- 歷史最高 176.5657
- 量 比 0.41
- 振 幅 3.48%
- 歷史最低 1.98
- 每 手 1
- 風險率 30.79%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美国柴油首破6美元压垮传统货运，却给特斯拉(TSLA.US)Semi铺了条“黄金跑道”？
美国柴油价格史上首次突破每加仑6美元大关，给深陷成本压力的货运行业投下一枚重磅炸弹，但也让特斯拉(TSLA.US)Semi电动卡车与自动驾驶卡车业务站上了资本市...
09-11 20:33
Industrials take top overweight spot: Ten stocks stand out on Quant ratings
With Industrials emerging as the largest overweight sector among U.S. funds, according to Variant Perception, attention is turning to individual companies that stand out within the space. As of Aug. 2...
08-31 22:46
Full steam ahead: The Union Pacific-Norfolk Southern merger review is moving forward
The Surface Transportation Board restarted its review of Union Pacific's (UNP) proposed merger with Norfolk Southern (NSC). Notably, the board had paused the case while it asked the companies for more...
08-19 22:02
美股大行评级 | 潜在涨幅3586.64%！HC Wainwright上调Enlivex目标价至80美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Enlivex"买入"评级，目标价从20美元升至80美元；Canaccord Genuity：维持Pharming Group NV Sponsored ADR"买入"评级，目标价从37美元升至38美元
08-04 11:45
美股大行评级 | 绩后重锤！Meta惨遭16家大行下调目标价；高通、Arm、泛林集团、波士顿科学也遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持TOMI Environmental Solutions"买入"评级，目标价从3.5美元升至7美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从107美元升至114美元
07-31 11:43
TD Cowen Maintains Hold on ArcBest, Lowers Price Target to $155
TD Cowen analyst Jason H. Seidl maintains ArcBest (NASDAQ:ARCB) with a Hold and lowers the price target from $175 to $155.
07-30 23:37
ArcBest shares are trading lower. The company reported its Q2 financial results.
ArcBest shares are trading lower. The company reported its Q2 financial results.
07-29 22:55
财报速睇 | ArcBest 2026财年Q2营收11.85亿美元，同比增长15.9%；归母净利润亏损0.14亿美元，由盈转亏
华盛资讯7月29日讯，ArcBest公布2026财年Q2业绩，公司Q2营收11.85亿美元，同比增长15.9%，归母净利润亏损0.14亿美元，由盈转亏。
07-29 18:29
ArcBest Q2 Adj. EPS $2.38 Beats $2.27 Estimate, Sales $1.185B Beat $1.166B Estimate
ArcBest (NASDAQ:ARCB) reported quarterly earnings of $2.38 per share which beat the analyst consensus estimate of $2.27 by 4.85 percent. This is a 75 percent increase over earnings of $1.36 per share from the same period last year. The company reported quarterly sales of $1.185 billion which beat th...
07-29 18:03
美股大行评级 | 富国银行上调亚马逊目标价从313美元升至322美元；潜在涨幅370.99%！HC Wainwright上调Greenwich LifeSciences目标价至69美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Greenwich LifeSciences"买入"评级，目标价从50美元升至69美元；高盛：维持Taysha Gene Therapies"买入"评级，目标价从11美元升至13美元
07-22 11:35
